Cure Alzheimer's Fund Achieves 13th Consecutive Perfect Score from Charity Navigator

Cure Alzheimer's Fund (CureAlz) has once again demonstrated its exceptional commitment to financial transparency and impactful research by earning a perfect score and Four-Star rating from Charity Navigator for the 13th consecutive year. This remarkable achievement places CureAlz among an elite group of nonprofits, with fewer than one-tenth of one percent of evaluated organizations receiving such a distinction. The recognition is a testament to the organization's dedication to responsible stewardship of donor contributions and its significant impact in the fight against Alzheimer's disease.

Charity Navigator's evaluation, based on four key metrics—Impact and Measurement, Accountability and Finance, Culture and Community, and Leadership and Adaptability—highlights CureAlz's operational excellence. The Four-Star rating not only designates CureAlz as a 'Give with Confidence' charity but also underscores its high impact in Alzheimer's research, fiscal responsibility, and adherence to best practices. This is particularly significant given Charity Navigator's extensive assessment of over 230,000 organizations since 2001.

Since its inception in 2004, Cure Alzheimer's Fund has allocated over $219 million in research funding through 917 grants to more than 300 leading researchers worldwide. These efforts have led to critical breakthroughs in understanding Alzheimer's disease. A distinctive feature of CureAlz's financial model is that 100% of general donations go directly into research, thanks to the organization's Board of Directors, Trustees, and a core group of donors who cover overhead expenses.

The consistent recognition from Charity Navigator, along with a Platinum Seal of Transparency from Candid, reinforces CureAlz's position as a trusted leader in nonprofit management and Alzheimer's research. This track record not only sets a high standard for nonprofit organizations in the medical research field but also offers hope to the millions affected by Alzheimer's disease, showcasing the profound impact of charitable giving and responsible nonprofit management.